Thursday, April 24, 2014 | 6:00 PM - 9:00 PM
Speakers: Parker Emerson (Yale University), Joann Halpern (German Center for Research and Innovation), Terrie Taylor (Michigan State University)
A new and exciting event that will provide an introduction to communicating and networking with scientists and professionals from different cultures.
Thursday, November 6, 2014 | 8:00 AM - 5:00 PM
Keynote Speakers: Robert E. Brackett (Illinois Institute of Technology), Frank Yiannas (Walmart)
Speakers: David Acheson (The Acheson Group, LLC), Carol Byrd-Bredbenner (Rutgers University), Benjamin Chapman (North Carolina State University), Marjorie Nolan Cohn (Academy of Nutrition and Dietetics), Jeff Farber (Bureau of Microbial Hazards, Health Canada), Linda J. Harris (UC Davis), Tanya Roberts (Center for Foodborne Illness Research and Prevention), Manpreet Singh (Purdue University), Kevin Haninger (U.S. Department of Health and Human Services)
This conference will discuss issues of food security, economics, policy and communication related to food safety.
Wednesday, February 5, 2014 | 7:00 PM - 8:30 PM
Featuring: Allan Kellehear, Jeffrey J. Kripal, and Lani Leary
Moderator: Steve Paulson
How do we cope with the inevitability of our mortality? Experts in psychology, philosophy and sociology come together to share a multicultural perspective on death, dying, and what lies beyond.
Wednesday, December 11, 2013 | 7:00 PM - 8:30 PM
Featuring: Peter Fenwick, Kevin Nelson, Mary Neal, Sam Parnia
Moderator: Steve Paulson
What happens when we die? Recent medical advances have led to increased reports of "out of body" or "near death" experiences. Can these experiences be explained, and what can we learn from the transformative accounts of those who have nearly died?
Thursday, November 21, 2013 | 8:00 AM - 5:00 PM
Keynote Speaker: Sally Tinkle (IDA/Science and Technology Policy Institute)
Featured Speakers: Yechezkel (Chezy) Barenholz (Hebrew University-Hadassah Medical School), Raj Bawa (Bawa Biotech LLC and Rensselaer Polytechnic Institute), Gerrit Borchard (University of Geneva, University of Lausanne), Ricardo Carvajal (Hyman, Phelps & McNamara, P.C.), Neil Desai (Abraxis Bioscience, A wholly owned subsidiary of Celgene Corporation), Rogério Gaspar (University of Lisbon), Patrick Hunziker (University Hospital Basel), Laurent Levy (Nanobiotix), Scott E. McNeil (Nanotechnology Characterization Laboratory – Frederick National Laboratory for Cancer Research), Stefan Mühlebach (Vifor Pharma Ltd. and University of Basel), Ritu Nalubola (US Food and Drug Administration), Lawrence Tamarkin (Cytimmune)
Explore regulatory challenges in the nascent field of nanomedicines including the relevance and adequacy of existing frameworks, availability and expertise of regulators, and safety concerns.
Tuesday, November 12, 2013 | 7:00 PM - 8:30 PM
Featuring: Christopher Comfort, Barbara Coombs Lee, Sam Shemie, and Mildred Z. Solomon
Moderator: Steve Paulson
As lifesaving technologies continue to advance, how should medical and financial resources be used to prolong the lives of patients suspended between life and death? Panelists weigh the legal, ethical, and social implications of such decisions.
Edited by Juan Pablo Peña-Rosas
(World Health Organization, Geneva, Switzerland), Maria Nieves Garcia-Casal
(Venezuelan Institute for Scientific Research, Caracas, Venezuela), and Helena Pachón
(Flour Fortification Initiative and Emory University, Atlanta, Georgia)
This Annals volume explores fortification of staple foods with micronutrients as a public health intervention, with a special focus on technical considerations for maize flour and corn meal.
Free online access provide by the Sackler Institute for Nutrition Science and the World Health Organization
Team Leaders: Paul Aisen (University of California, San Diego), Russell L. Barton (Eli Lilly and Company), Randall J. Bateman (Washington University), Howard Feldman (University of British Columbia, Canada), Michael T. Ropacki (Janssen Research & Development), Andrew Satlin (Eisai Inc.), Eric R. Siemers (Eli Lilly and Company), Reisa A. Sperling (Harvard Medical School), and Luc Truyen (Johnson & Johnson)
The Global Alzheimer's Platform (GAP) aims to establish a drug discovery process to expedite AD research. This eBriefing documents a workshop convened to plan how to build the platform.
Organizers: Raj Bawa (Bawa Biotech LLC; Rensselaer Polytechnic Institute), Scott E. McNeil
(Nanotechnology Characterization Laboratory – Frederick National Laboratory for Cancer Research), Stefan Mühlebach (Vifor Pharma Ltd.; University of Basel, Switzerland), Melanie Brickman Stynes (The New York Academy of Sciences), and Melinda Miller (The New York Academy of Sciences)
Keynote Speaker: Sally Tinkle (Science and Technology Policy Institute, IDA)
This eBriefing explores regulatory challenges in the nascent field of nanomedicines.
Keynote Speakers: Yuko Harayama (Council for Science and Technology Policy, Cabinet Office, Japan), Richard J. Hodes (National Institute on Aging, NIH), Jan M. Lundberg (Eli Lilly and Company), and Bengt Winblad (Karolinska Institute, Sweden)
This eBriefing outlines a research agenda crafted by leading industry, academic, and government stakeholders to advance the goals of the U.S. National Alzheimer's Plan.
With our economy a shambles and our environment threatened, is there any reason to be optimistic about the future? Matt Ridley says there's scientific proof to say we should be.
According to the New York City Panel on Climate Change, global warming could have a big impact on the five boroughs. Three experts discuss the Panel's recent findings, and tell us what weather and policy changes to expect.
Richard Dawkins launches his newest book in the third S&C Provocative Thinkers in Science event. He argues evolution is an indisputable fact, despite nearly half of Americans believing the opposite.
Translational Medicine Initiative
The Translational Medicine Initiative represents a three-year partnership between the New York Academy of Sciences and the Josiah Macy, Jr. Foundation to support the translation of basic science research into clinical applications.
Learn more at www.nyas.org/TransMed.